Majdi Osman

35.6k total citations
40 papers, 641 citations indexed

About

Majdi Osman is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Majdi Osman has authored 40 papers receiving a total of 641 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Infectious Diseases, 23 papers in Molecular Biology and 13 papers in Epidemiology. Recurrent topics in Majdi Osman's work include Clostridium difficile and Clostridium perfringens research (34 papers), Gut microbiota and health (23 papers) and Microscopic Colitis (9 papers). Majdi Osman is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (34 papers), Gut microbiota and health (23 papers) and Microscopic Colitis (9 papers). Majdi Osman collaborates with scholars based in United States, Canada and United Kingdom. Majdi Osman's co-authors include Zain Kassam, Shrish Budree, Jessica R. Allegretti, Caroline Zellmer, Monika Fischer, Melanie B. White, Chathur Acharya, Mary L. Holtz, Nita H. Salzman and Mohammad Shadab Siddiqui and has published in prestigious journals such as Nature, Gastroenterology and PLoS ONE.

In The Last Decade

Majdi Osman

38 papers receiving 617 citations

Peers

Majdi Osman
Srishti Saha United States
Marisela Silva United States
Christopher Schriever United States
Thimmaiah Theethira United States
Maame Efua Sampah United States
Andrew M Skinner United States
Malte Schütz United States
Srishti Saha United States
Majdi Osman
Citations per year, relative to Majdi Osman Majdi Osman (= 1×) peers Srishti Saha

Countries citing papers authored by Majdi Osman

Since Specialization
Citations

This map shows the geographic impact of Majdi Osman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Majdi Osman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Majdi Osman more than expected).

Fields of papers citing papers by Majdi Osman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Majdi Osman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Majdi Osman. The network helps show where Majdi Osman may publish in the future.

Co-authorship network of co-authors of Majdi Osman

This figure shows the co-authorship network connecting the top 25 collaborators of Majdi Osman. A scholar is included among the top collaborators of Majdi Osman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Majdi Osman. Majdi Osman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Browne, Hilary P., Najeeha Talat Iqbal, Majdi Osman, et al.. (2024). Boosting microbiome science worldwide could save millions of children’s lives. Nature. 625(7994). 237–240. 11 indexed citations
2.
Tadesse, Birkneh Tilahun, Karen H. Keddy, Natasha Y. Rickett, et al.. (2023). Vaccination to Reduce Antimicrobial Resistance Burden—Data Gaps and Future Research. Clinical Infectious Diseases. 77(Supplement_7). S597–S607. 4 indexed citations
3.
Liu, Christine K., Susan K. Frazier, Gary H. Brandeis, et al.. (2022). Pilot study of autologous fecal microbiota transplants in nursing home residents: Feasibility and safety. Contemporary Clinical Trials Communications. 27. 100906–100906. 4 indexed citations
4.
Harrington, Amanda, et al.. (2022). Clinical Manifestations and Stool Load of Atypical Enteropathogenic Escherichia coli Infections in United States Children and Adults. Gastroenterology. 163(5). 1321–1333. 9 indexed citations
5.
Olesen, Scott W., et al.. (2020). Modeling Donor Screening Strategies to Reduce the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Transmission via Fecal Microbiota Transplantation. Open Forum Infectious Diseases. 7(11). ofaa499–ofaa499. 2 indexed citations
6.
Allegretti, Jessica R., Ryan J. Elliott, Alim Ladha, et al.. (2020). Stool processing speed and storage duration do not impact the clinical effectiveness of fecal microbiota transplantation. Gut Microbes. 11(6). 1806–1808. 16 indexed citations
7.
Santiago, Marina, Jessica R. Allegretti, Olga C. Aroniadis, et al.. (2019). Microbiome predictors of dysbiosis and VRE decolonization in patients with recurrent C. difficile infections in a multi-center retrospective study. PMC. 3 indexed citations
8.
Santiago, Marina, Jessica R. Allegretti, Olga C. Aroniadis, et al.. (2019). Microbiome predictors of dysbiosis and VRE decolonization in patients with recurrent <em>C. difficile</em> infections in a multi-center retrospective study. AIMS Microbiology. 5(1). 1–18. 14 indexed citations
9.
Duvallet, Claire, Caroline Zellmer, Pratik Panchal, et al.. (2019). Framework for rational donor selection in fecal microbiota transplant clinical trials. PLoS ONE. 14(10). e0222881–e0222881. 31 indexed citations
10.
Bajaj, Jasmohan S., Nita H. Salzman, Chathur Acharya, et al.. (2019). Fecal Microbial Transplant Capsules Are Safe in Hepatic Encephalopathy: A Phase 1, Randomized, Placebo‐Controlled Trial. Hepatology. 70(5). 1690–1703. 226 indexed citations
11.
Kassam, Zain, Nancy Dubois, Taha Qazi, et al.. (2019). 512 – Donor Health Screening for Fecal Microbiota Transplantation: Prospective Evaluation of 15,317 Candidate Donors. Gastroenterology. 156(6). S–100. 6 indexed citations
12.
Bajaj, Jasmohan S., Nita H. Salzman, Chathur Acharya, et al.. (2019). PS-087-Fecal microbiota capsules are safe and effective in patients with recurrent hepatic encephalopathy: A randomized, blinded, placebo-controlled trial. Journal of Hepatology. 70(1). e55–e55. 1 indexed citations
13.
Kassam, Zain, et al.. (2018). Stool Donor Demographics and Performance Indicators: Evidence From 223 Enrolled Stool Donors. The American Journal of Gastroenterology. 113(Supplement). S1590–S1590. 1 indexed citations
14.
Panchal, Pratik, Shrish Budree, Wing Fei Wong, et al.. (2018). Scaling Safe Access to Fecal Microbiota Transplantation: Past, Present, and Future. Current Gastroenterology Reports. 20(4). 14–14. 35 indexed citations
15.
Allegretti, Jessica R., Zain Kassam, Majdi Osman, et al.. (2017). The 5D framework: a clinical primer for fecal microbiota transplantation to treat Clostridium difficile infection. Gastrointestinal Endoscopy. 87(1). 18–29. 45 indexed citations
16.
Budree, Shrish, Jessica R. Allegretti, Monika Fischer, et al.. (2017). The Association of Donor Stool Consistency by Bristol Stool Scale on Microbial Profile and Clinical Outcomes of Fecal Microbiota Transplantation in Clostridium Difficile Infection. Gastroenterology. 152(5). S630–S630. 3 indexed citations
17.
Osman, Majdi, Kelsey OʼBrien, Nancy Dubois, et al.. (2016). Safety and Efficacy of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection From An International Public Stool Bank: Results From a 2050-Patient Multicenter Cohort. Open Forum Infectious Diseases. 3(suppl_1). 17 indexed citations
18.
Dubois, Nancy, Kelsey OʼBrien, Pratik Panchal, et al.. (2016). Prospective Laboratory Evaluation of Fecal Microbiota Transplantation Donors: Results From an International Public Stool Bank. Open Forum Infectious Diseases. 3(suppl_1). 3 indexed citations
19.
Dubrey, Simon W, et al.. (2012). A puzzling tumour. Thorax. 67(12). 1116–1118.
20.
Denno, Donna M., Venkatraman Chandra‐Mouli, & Majdi Osman. (2012). Reaching Youth With Out-of-Facility HIV and Reproductive Health Services: A Systematic Review. Journal of Adolescent Health. 51(2). 106–121. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026